Innovating for the Benefit of Patients in Medical Cannabis (Opinion)
Poor bioavailability formulations in orally delivered medical cannabis have left an innovation gap for patients.
Poor bioavailability formulations in orally delivered medical cannabis have left an innovation gap for patients.